C. Rubinstein et al., THE ROLE OF THE KIDNEY IN THE CLEARANCE OF CALCITONIN-GENE-RELATED PEPTIDE (CGRP), Australian and New Zealand journal of surgery, 64(4), 1994, pp. 266-269
Calcitonin gene-related peptide (CGRP) is a 37 amino-acid peptide, und
etectable in the plasma in health but elevated in certain disease stat
es such as medullary thyroid cancer, and potentially causes symptoms.
The kidney is a major site of and influence on the clearance of exogen
ously infused CGRP. As CGRP might cause symptoms in renal dysfunction,
this study was performed to determine the clearance of CGRP in humans
and animals with altered renal function. In chronic renal failure pat
ients, CGRP was not detected in plasma either before or after haemodia
lysis. In sheep, before and after bilateral nephrectomy, there was an
approximate halving of plasma clearance and doubling of the circulatin
g half-life of infused CGRP. This reduction in clearance was greater t
han that which could be accounted for by the reduction in degradation
by renal substance alone. This renal influence on extra-renal CGRP met
abolism was not due to the renal production of a circulating peptidase
as evidenced by the absence of such peptidase in the plasma of normal
and anephric sheep. Further, severity of uraemia had no influence on
the extra-renal metabolism. The mechanism by which the kidney influenc
es the extra-renal metabolism of CGRP remains obscure.